The trial had a 26-week treatment period, including a 6-week dose-escalation period, and a 6-week follow-up period without treatment
When the generic product differs in formulation from the RLD, additional in vivo pharmacokinetic and clinical efficacy studies are required
Prescription medications can also be ordered with a valid prescription, subject to applicable regulations
These results suggest a potential regulatory relationship between thymosin beta 4, microRNA 146a expression, and downstream inflammatory pathway modulation
Based on our review of the application, we agree with the applicant and have determined that the Axoguard HA+ Nerve Protector TM meets the eligibility criterion at 419.66(b)(3)
As a hexapeptide derivative, Dihexa has drawn significant attention in the scientific community due to its capacity to influence molecular pathways associated with synaptic plasticity and cognitive function